Home » Topics » Regulatory

Regulatory
RSS

Xarelto approved in Canada for prevention of venous thromboembolic events

Sep. 17, 2008

FDA approves Gamunex for inflammatory demyelinating polyneuropathy

Sep. 17, 2008

Vimpat approved in the E.U. for partial-onset seizures

Sep. 3, 2008

SF-1019 approved in Malaysia

Aug. 13, 2008

FDA approves Cleviprex for hypertension when oral therapy is not feasible

Aug. 5, 2008

European Commission approves Schering-Plough's Bridion

July 30, 2008

Health Canada grants approval to Santhera's Catena in Friedreich's ataxia

July 25, 2008

Jerini receives European approval for Firazyr for hereditary angioedema

July 16, 2008

Tredaptive approved in E.U. for dyslipidemia and primary hypercholesterolemia

July 14, 2008

Health Canada grants marketing authorization to Basilea's Zeftera for cSSSI

July 2, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...